(Q39736181)

14 September 2017

0 references

Fatty Acid synthase inhibitors as possible treatment for cancer: patent highlight (English)

1 reference

14 September 2017

0 references

Ahmed F Abdel-Magid

1

1 reference

14 September 2017

5 July 2012

1 reference

ACS Medicinal Chemistry Letters

14 September 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 September 2017

3

1 reference

14 September 2017

8

1 reference

14 September 2017

612-613

1 reference

Anti-cancer drugs targeting fatty acid synthase (FAS).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025849

Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025849

Acetyl-CoA carboxylase-a as a novel target for cancer therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025849

Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4025849

14 September 2017

Identifiers

DOI

10.1021/ML3001566

1 reference

14 September 2017

1 reference

PMC publication ID

4025849

14 September 2017

PubMed publication ID

24900519

1 reference

PMC publication ID

4025849